Nu Skin Enterprises Stock Market Outlook
| NUS Stock | USD 7.33 0.28 3.97% |
The ratio of positive to negative mentions in recent coverage offers a snapshot of where public discussion currently leans, but the reading remains only one part of the overall model. Around 55% of recent sentiment around Nu Skin has been mildly constructive over the recent sample. Taken on its own, that leaves the current sentiment reading for Nu Skin Enterprises close to neutral currently.
Investor Comfort Level
Impartial
55
PanicConfidence
Elasticity to Hype and News Sentiment
Nu Skin Enterprises news sentiment reading of 50% (mixed) tracks how media and analyst commentary are framing the investment case. That reading becomes more actionable when paired with valuation context and recent technical trend direction.
Over a 90-day investment horizon, with an above-average risk tolerance, the model output for Nu Skin Enterprises is 'Strong Sell'. The directional recommendation for Nu Skin Enterprises is produced by a quantitative model processing multiple data inputs. Market positioning data and performance patterns are combined to generate the signal. Macroaxis buy or sell analysis combines algorithmic processing with current market condition assessment. This signal serves as one input among several in the investment decision-making process.
NUS |
Run Nu Skin Outlook Model
The NUS model signal below complements and cross-checks analyst coverage of Nu Skin Enterprises. Macroaxis is fully independent and carries no interest in Nu Skin Enterprises or related covered assets. The Nu Skin's module uses market data together with historical trend analysis. This quantitative perspective adds context to analyst commentary on Nu Skin Enterprises.
How This Model Works
The recommendation output for Nu Skin is a model-based view that converts the selected horizon and risk profile into a standardized reading of the current evidence.
- Inputs - valuation signals, price behavior, volatility, liquidity, sentiment, and analyst coverage when available
- Current setup - Three Months with a risk setting described as I am an educated risk taker
- Limits - the model does not account for taxes, outside holdings, concentration constraints, or investor-specific mandates
Use the output as structured decision support and pair it with your own research, portfolio context, and any professional advice you rely on.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Weak | Details | |
Volatility | Slightly Elevated | Details | |
Current Valuation | Above Model Estimate | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Nu Skin's current outlook reflects a cautious setup, where recent market performance has undercut momentum, while contained volatility and intact fundamental quality provide partial offset. The model's 'Strong Sell' signal reflects persistent headwinds that outweigh the offsetting factors in the model. For the selected horizon, Nu Skin yields Mean Deviation of 1.95, Standard Deviation of 3.19, and Variance of 10.15, which weigh on the current risk-reward outlook.This quantitative reading for Nu Skin is derived from a multi-factor model that evaluates current market conditions, fundamental quality, and momentum alongside the expert outlook. For additional context on this small-cap stock, assess the full set of Nu Skin reported fundamentals, including debt to equity ttm, price to earnings to growth, and the relationship between the gross profit ttm and retained earnings ttm. With a price to earnings ttm of 10.70 X. Nu Skin's market performance and bankruptcy risk are relevant reference points going forward.
Recent Events and Market Context
The events below reflect recent headlines associated with Nu Skin. Not all items directly affect the outlook — they are included to show the broader information environment that can shape sentiment and trading behavior.
Returns Distribution Density
For Nu Skin, this chart shows how daily price changes have been distributed. The width of the curve reflects aggregate price volatility for Nu Skin. Value At Risk captures the downside tail and Upside Potential captures the upside. The center is the most frequent outcome while the tails show how extreme the swings have been historically.
| Mean Return | -0.5 | Value At Risk | -4.72 | Potential Upside | 3.17 | Standard Deviation | 3.19 |
Return Density |
| Distribution |
How extreme have Nu Skin's daily price moves been historically? The return chart below shows exactly that for Nu Skin. It allows side-by-side comparison of risk-return profiles on a risk-adjusted basis. The tails of Nu Skin's return distribution are where the most consequential risk information lies.
Key Drivers of Volatility and Market Exposure
Nu Skin exhibits both macro-linked volatility and company or sector-specific developments. Beta and standard deviation quantify relative market risk. Nu Skin Enterprises (NUS) recorded a Mean Deviation of 1.95 and a Standard Deviation of 3.19.
α | Alpha over Dow Jones | -0.5111 | |
β | Beta against Dow Jones | 0.17 | |
σ | Overall volatility | 3.19 | |
Ir | Information ratio | -0.1622 |
Fundamentals Vs Peers
Relative fundamental analysis for Nu Skin puts the stock's operating metrics in a competitive context. Peer comparison for Nu Skin converts standalone metrics into a relative ranking that sharpens the investment case. Nu Skin's financial indicators tested against comparable stocks identify which metrics are driving relative valuation. Peer analysis extends standalone financial analysis for Nu Skin into a competitive framework.
| Better Than Average | Worse Than Average | Compare Nu Skin to competition |
Note: Acquisition by Justin Keisel of 47059 shares of Nu Skin subject to Rule 16 b-3 [view details]
Market Momentum
Nu Skin Enterprises mildly bearish RSI of 40 combined with low-beta sensitivity (0.1739) reveals whether current momentum is driven by company-specific demand or market-wide flows. Comparing these readings with volume and earnings revisions strengthens the signal since the signal is more company-driven than market-linked.
Recommendation Framework, Assumptions & Editorial Oversight
The model output for Nu Skin reflects the current horizon and risk settings, refreshes as underlying data changes, and is intended to organize evidence rather than replace investor judgment. Current model inputs for Nu Skin include P/E of 10.7, ROE of 22.0%. 
Nu Skin Enterprises analytics rely on periodic company reporting and market reference feeds, with quality checks and normalization applied. The model combines valuation, price behavior, volatility, and sentiment into a standardized quantitative view.
Editorial Review & Methodology Oversight
Role: Junior Member of Macroaxis Editorial Board
Finance background: Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
Oversight scope: Reviews recommendation-framework framing, source assumptions, and disclosure language.